JILL DUNHAM: Open Payments
NPI 1700235942 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 14 payments from 7 companies in 2025. Trend: 2023 $216 · 2024 $488 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Tempus AI, Inc | 2 | $99 |
| Incyte Corporation | 2 | $47 |
| PFIZER INC. | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| BeOne Medicines USA, Inc. | 1 | $26 |
| SERVIER PHARMACEUTICALS LLC | 1 | $17 |
Products named: XT CDX, IBRANCE, KISQALI, KEYTRUDA QLEX, MONJUVI, BRUKINSA, Fabhalta, SCEMBLIX.
Industry payments across MI — which companies pay providers there.
